– Completed Initial Public Offering (IPO) of common stock, raising gross proceeds of $82.1M
– Single Ascending Dose (SAD) portion of Phase 1 study of CMP-CPS-001 completed; safety data anticipated in Q1 2025
– Entered strategic research collaboration with BioMarin valued at over $370M
GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Latest posts by GlobeNewswire (see all)
- JP 3E Holdings, Inc. Completes Acquisition of MetaRock and its Patented Trade Platform; World’s First Decentralized Metaverse Technology - July 1, 2025
- Carson Group Fully Acquires Jacob William Advisory in Maryland - July 1, 2025
- SANS 2025 SOC Survey Exposes Critical Gaps and What Top Teams Are Doing Right - July 1, 2025
